DarioHealth is a publicly traded digital health company that develops technology for the management of chronic and behavioral health conditions. Its Dario digital health platform combines mobile applications, connected health devices, data-driven insights and analytics, and live coaching to deliver personalized, evidence-based care. The company was founded in Delaware in 2011 and is headquartered in New York; it trades on Nasdaq under the ticker DRIO.
The company's technical work spans mobile health applications, connected health devices, behavioral health technology, chronic disease management and data-driven analytics. These capabilities are applied across conditions including diabetes, hypertension, weight management, musculoskeletal care and behavioral health, such as anxiety, depression and stress.
DarioHealth serves health plans, health systems, employers, consultants and pharmaceutical partners in the United States. Its stated approach combines consumer-friendly technology with clinical programmes, supported by real-time and live human support from personal coaches, with an emphasis on evidence-based care and sustainable behaviour change intended to improve engagement, health outcomes and cost efficiency.
